Genetic interleukin-10 deficiency causes vascular remodeling via the upregulation of Nox1

Journal of Hypertension

Volumn 29, Issue 11, 2011, Pages 2116-2125

  Dammanahalli, Jagadeesha K ^a   Wang, Xiuqing ^a   Sun, Zhongjie ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

adeno associated virus; endothelin 1; interleukin 6; matrix metalloproteinase 9; NADPH oxidase; superoxide; vascular remodeling; vascular smooth muscle cell

Indexed keywords

COLLAGEN; ENDOTHELIN 1; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 6; PARVOVIRUS VECTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; SUPEROXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC ANALYSIS; HEART VENTRICLE REMODELING; INTERLEUKIN 10 DEFICIENCY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; RNA INTERFERENCE; SMOOTH MUSCLE FIBER; UPREGULATION;

EID: 80054113073     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834b22a0     Document Type: Article

References (52)

1. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19:683-765. (Pubitemid 32368050)
2. Krakauer T. IL-10 inhibits the adhesion of leukocytic cells to IL-1-activated human endothelial cells. Immunol Lett 1995; 45:61-65.
3. Barillari G, Albonici L, Incerpi S, Bogetto L, Pistritto G, Volpi A, et al. Inflammatory cytokines stimulate vascular smooth muscle cells locomotion and growth by enhancing alpha5beta1 integrin expression and function. Atherosclerosis 2001; 154:377-385. (Pubitemid 32146610)
4. Gunnett CA, Heistad DD, Berg DJ, Faraci FM. IL-10 deficiency increases superoxide and endothelial dysfunction during inflammation. Am J Physiol Heart Circ Physiol 2000; 279:H1555-H1562.
5. Zemse SM, Hilgers RH, Webb RC. Interleukin-10 counteracts impaired endothelium-dependent relaxation induced by ANG II in murine aortic rings. Am J Physiol Heart Circ Physiol 2007; 292:H3103-H3108. (Pubitemid 47084565)
6. Keaney JF Jr. Oxidative stress and the vascular wall: NADPH oxidases take center stage. Circulation 2005; 112:2585-2588. (Pubitemid 41532593)
7. Geiszt M, Leto TL. The Nox family of NAD(P)H oxidases: host defense and beyond. J Biol Chem 2004; 279:51715-51718. (Pubitemid 39656535)
8. Lambeth JD, Cheng G, Arnold RS, Edens WA. Novel homologs of gp91phox. Trends Biochem Sci 2000; 25:459-461.
9. Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, et al. Cell transformation by the superoxide-generating oxidase Mox1. Nature 1999; 401:79-82.
10. Banfi B, Maturana A, Jaconi S, Arnaudeau S, Laforge T, Sinha B, et al. A mammalian H\+ channel generated through alternative splicing of the NADPH oxidase homolog NOH-1. Science 2000; 287:138-142.
11. Lassegue B, Sorescu D, Szocs K, Yin Q, Akers M, Zhang Y, et al. Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 2001; 88:888-894. (Pubitemid 32441466)
12. Dikalova A, Clempus R, Lassegue B, Cheng G, McCoy J, Dikalov S, et al. Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation 2005; 112:2668-2676. (Pubitemid 41532604)
13. Yoshioka T, Okada T, Maeda Y, Ikeda U, Shimpo M, Nomoto T, et al. Adeno-associated virus vector-mediated interleukin-10 gene transfer inhibits atherosclerosis in apolipoprotein E-deficient mice. Gene Ther 2004; 11:1772-1779. (Pubitemid 40028538)
14. Nomoto T, Okada T, Shimazaki K, Yoshioka T, Nonaka-Sarukawa M, Ito T, et al. Systemic delivery of IL-10 by an AAV vector prevents vascular remodeling and end-organ damage in stroke-prone spontaneously hypertensive rat. Gene Ther 2009; 16:383-391.
15. Nonaka-Sarukawa M, Okada T, Ito T, Yamamoto K, Yoshioka T, Nomoto T, et al. Adeno-associated virus vector-mediated systemic interleukin-10 expression ameliorates hypertensive organ damage in Dahl salt-sensitive rats. J Gene Med 2008; 10:368-374. (Pubitemid 351517092)
16. Sun Z, Bello-Roufai M, Wang X. RNAi inhibition of mineralocorticoid receptors prevents the development of cold-induced hypertension. Am J Physiol Heart Circ Physiol 2008; 294:H1880-H1887. (Pubitemid 351490617)
17. Wang X, Skelley L, Cade R, Sun Z. AAV delivery of mineralocorticoid receptor shRNA prevents progression of cold-induced hypertension and attenuates renal damage. Gene Ther 2006; 13:1097-1103.
18. Wang X, Sun Z. RNAi silencing of brain klotho potentiates cold-induced elevation of blood pressure via the endothelin pathway. Physiol Genomics 2010.
19. Wang Y, Sun Z. Klotho gene delivery prevents the progression of spontaneous hypertension and renal damage. Hypertension 2009; 54:810-817.
20. Zuo Z, Lei H, Wang X, Wang Y, Sonntag W, Sun Z. Aging-related kidney damage is associated with a decrease in klotho expression and an increase in superoxide production. Age (Dordr) 2010; 10:10.
21. Rey FE, Cifuentes ME, Kiarash A, Quinn MT, Pagano PJ. Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. Circ Res 2001; 89:408-414. (Pubitemid 34132656)
22. Schulz E, Munzel T. NOX5, a new 'radical' player in human atherosclerosis? J Am Coll Cardiol 2008; 52:1810-1812.
23. Ray JL, Leach R, Herbert JM, Benson M. Isolation of vascular smooth muscle cells from a single murine aorta. Methods Cell Sci 2001; 23:185-188. (Pubitemid 34863290)
24. Galis ZS, Johnson C, Godin D, Magid R, Shipley JM, Senior RM, Ivan E. Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ Res 2002; 91:852-859. (Pubitemid 35285084)
25. Godin D, Ivan E, Johnson C, Magid R, Galis ZS. Remodeling of carotid artery is associated with increased expression of matrix metalloproteinases in mouse blood flow cessation model. Circulation 2000; 102:2861-2866.
26. Dammanahalli JK, Sun Z. Endothelin (ET)-1 inhibits nicotinamide adenine dinucleotide phosphate oxidase activity in human abdominal aortic endothelial cells: a novel function of ETB1 receptors. Endocrinology 2008; 149:4979-4987.
27. Parker JL, Myers PR, Zhong Q, Kim K, Adams HR. Inhibition of endotheliumdependent vasodilation by Escherichia coli endotoxemia. Shock 1994; 2:451-458.
28. Vila E, Salaices M. Cytokines and vascular reactivity in resistance arteries. Am J Physiol Heart Circ Physiol 2005; 288:H1016-H1021. (Pubitemid 40270001)
29. Crosswhite P, Sun Z. Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension. J Hypertens 2010; 28:201-212.
30. Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF, et al. Protective role of interleukin-10 in atherosclerosis. Circ Res 1999; 85:e17-e24.
31. Dammanahalli KJ, Sun Z. Endothelins and NADPH oxidases in the cardiovascular system. Clin Exp Pharmacol Physiol 2008; 35:2-6. (Pubitemid 350197691)
32. Cai H, Griendling KK, Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 2003; 24:471-478. (Pubitemid 37088172)
33. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000; 86:494-501. (Pubitemid 30165039)
34. Fortuno A, San Jose G, Moreno MU, Diez J, Zalba G. Oxidative stress and vascular remodelling. Exp Physiol 2005; 90:457-462. (Pubitemid 40980145)
35. Wassmann S, Nickenig G. Interrelationship of free oxygen radicals and endothelial dysfunction: modulation by statins. Endothelium 2003; 10:23-33. (Pubitemid 36355980)
36. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996; 97:1916-1923.
37. Rokutan K, Kawahara T, Kuwano Y, Tominaga K, Nishida K, Teshima-Kondo S. Nox enzymes and oxidative stress in the immunopathology of the gastrointestinal tract. Semin Immunopathol 2008; 30:315-327.
38. Rokutan K, Kawahara T, Kuwano Y, Tominaga K, Sekiyama A, Teshima-Kondo S. NADPH oxidases in the gastrointestinal tract: a potential role of Nox1 in innate immune response and carcinogenesis. Antioxid Redox Signal 2006; 8 (9-10):1573-1582. (Pubitemid 44726332)
39. Leto TL, Geiszt M. Role of Nox family NADPH oxidases in host defense. Antioxid Redox Signal 2006; 8:1549-1561. (Pubitemid 44726330)
40. Agapitov AV, Haynes WG. Role of endothelin in cardiovascular disease. J Renin Angiotensin Aldosterone Syst 2002; 3:1-15. (Pubitemid 34475087)
41. Ferro CJ, Haynes WG, Johnston NR, Lomax CC, Newby DE, Webb DJ. The peptide endothelin receptor antagonist, TAK-044, produces sustained inhibition of endothelin-1 mediated arteriolar vasoconstriction. Br J Clin Pharmacol 1997; 44:377-383. (Pubitemid 27402113)
42. Touyz RM, Schiffrin EL. Role of endothelin in human hypertension. Can J Physiol Pharmacol 2003; 81:533-541. (Pubitemid 36836389)
43. Giachini FR, Zemse SM, Carneiro FS, Lima VV, Carneiro ZN, Callera GE, et al. Interleukin-10 attenuates vascular responses to endothelin-1 via effects on ERK1/2-dependent pathway. Am J Physiol Heart Circ Physiol 2009; 296:H489-H496.
44. Loftus IM, Thompson MM. The role of matrix metalloproteinases in vascular disease. Vasc Med 2002; 7:117-133. (Pubitemid 35203360)
45. Bouvet C, Moreau S, Blanchette J, de Blois D, Moreau P. Sequential activation of matrix metalloproteinase 9 and transforming growth factor beta in arterial elastocalcinosis. Arterioscler Thromb Vasc Biol 2008; 28:856-862. (Pubitemid 351544099)
46. Medley TL, Cole TJ, Dart AM, Gatzka CD, Kingwell BA. Matrix metalloproteinase-9 genotype influences large artery stiffness through effects on aortic gene and protein expression. Arterioscler Thromb Vasc Biol 2004; 24:1479-1484. (Pubitemid 39050444)
47. Hindson VJ, Ashworth JL, Rock MJ, Cunliffe S, Shuttleworth CA, Kielty CM. Fibrillin degradation by matrix metalloproteinases: identification of aminoand carboxy-terminal cleavage sites. FEBS Lett 1999; 452:195-198. (Pubitemid 29301743)
48. Tazaki T, Minoguchi K, Yokoe T, Samson KT, Minoguchi H, Tanaka A, et al. Increased levels and activity of matrix metalloproteinase-9 in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004; 170:1354-1359. (Pubitemid 39657200)
49. Li WG, Miller FJ Jr, Brown MR, Chatterjee P, Aylsworth GR, Shao J, et al. Enhanced H(2)O(2)-induced cytotoxicity in 'epithelioid' smooth muscle cells: implications for neointimal regression. Arterioscler Thromb Vasc Biol 2000; 20:1473-1479. (Pubitemid 30353876)
50. Pedruzzi E, Guichard C, Ollivier V, Driss F, Fay M, Prunet C, et al. NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells. Mol Cell Biol 2004; 24:10703-10717. (Pubitemid 39603128)
51. Jagadeesha DK, Lindley TE, Deleon J, Sharma RV, Miller F, Bhalla RC. Tempol therapy attenuates medial smooth muscle cell apoptosis and neointima formation after balloon catheter injury in carotid artery of diabetic rats. Am J Physiol Heart Circ Physiol 2005; 289:H1047-H1053. (Pubitemid 41208946)
52. Arnold RS, Shi J, Murad E, Whalen AM, Sun CQ, Polavarapu R, et al. Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1. Proc Natl Acad Sci USA 2001; 98:5550-5555. (Pubitemid 32435679)